These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4373254)

  • 1. Inhibition of oxytocic and hypotensive activities of bradykinin by bradykinin-binding antibodies.
    Marin Grez M; Marin Grez MS; Peters G
    Eur J Pharmacol; 1974 Nov; 29(1):35-42. PubMed ID: 4373254
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of 2-halogenoalkylamines on the biological activity of some peptides.
    Graham JD; Katib HA
    Br J Pharmacol Chemother; 1966 Aug; 27(2):377-86. PubMed ID: 4381778
    [No Abstract]   [Full Text] [Related]  

  • 3. Irreversible inhibition of angiotensin II activity on the rat uterus by an alkylating angiotensin derivative.
    Paiva TB; Miyamoto ME; Paiva AC
    Pharmacology; 1974; 12(3):186-91. PubMed ID: 4374707
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacology of a new oxytocic principle from ox hypothalamus.
    Hawker RW; North WG; Zerner B
    Br J Pharmacol; 1969 Jan; 35(1):175-86. PubMed ID: 5812485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some pharmacological properties of a synthetic oxytocin analogue [1-N-carbamoyl-hemicystine-2-O-methyltyrosine]-oxytocin (carbamoyl-methyloxytocin), an antagonist to the neurohypophysial hormones.
    Bisset GW; Clark BJ; Krejcí I; Polácek I; Rudinger J
    Br J Pharmacol; 1970 Oct; 40(2):342-60. PubMed ID: 4321760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Potentiation of the effects of oxytocin and vasopressin by the magnesium ion on the smooth muscle of isolated rat uterus].
    Ishida Y; Moritoki H
    Nihon Yakurigaku Zasshi; 1966 Nov; 62(6):398-403. PubMed ID: 6008361
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin-like and antagonistic activities of N-terminal modified (8-leucine)angiotensin II peptides.
    Paiva TB; Goissis G; Juliano L; Miyamoto ME; Paiva AC
    J Med Chem; 1974 Feb; 17(2):239-41. PubMed ID: 4358432
    [No Abstract]   [Full Text] [Related]  

  • 8. The inhibition of cationic myotropic drugs by compounds 48/80 and 46/108.
    Paiva TB; Paiva AC
    Biochem Pharmacol; 1966 Sep; 15(9):1303-8. PubMed ID: 4291040
    [No Abstract]   [Full Text] [Related]  

  • 9. The pressor and myotropic effects and the antagonistic properties of several analogues of angiotensin II.
    Regoli D; Park WK
    Can J Physiol Pharmacol; 1972 Feb; 50(2):99-112. PubMed ID: 4336727
    [No Abstract]   [Full Text] [Related]  

  • 10. New specific angiotensin antagonists. (8-Valine)-, (8-isoleucine)-, and chlorambucil-des-1-aspartic,8-valine-angiotensins I.
    Paiva AC; Nouaihetas VL; Miyamoto ME; Mendes GB; Paiva TB
    J Med Chem; 1973 Jan; 16(1):6-9. PubMed ID: 4344926
    [No Abstract]   [Full Text] [Related]  

  • 11. A pharmacologic analysis of the significance of the chemical functional groups of oxytocin to its oxytocic activity and on the effect of magnesium on the in vitro and in vivo oxytocic activity of neurohypophysial hormones.
    Chan WY; Kelley N
    J Pharmacol Exp Ther; 1967 Apr; 156(1):150-8. PubMed ID: 6023591
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacology of oxytocin-(1-6)-hexapeptide amide, vasopressin-(1-6)-hexapeptide amide and their deamino analogues.
    Krejcí I; Barth T; Kupková B; Fruhaufová L; Flegel M; Zaoral M
    Eur J Pharmacol; 1973 Nov; 24(2):179-82. PubMed ID: 4797284
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiotensin II. Synthesis and biological activity of 6-(1-methylhistidine) and 6-(3-methylhistidine) analogs.
    Needleman P; Marshall GR; Rivier J
    J Med Chem; 1973 Sep; 16(9):968-70. PubMed ID: 4355510
    [No Abstract]   [Full Text] [Related]  

  • 14. ACTIVITY OF ELEDOISIN, OTHER POLYPEPTIDES AND ERGOMETRINE ON THE UTERUS IN SITU OF RABBIT AND OTHER ANIMAL SPECIES.
    FREGNAN GB; GLAESSER AH
    J Pharm Pharmacol; 1964 Nov; 16():744-50. PubMed ID: 14241142
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological studies on isolated smooth muscle organs of the gold hamster].
    Daum A; Lembeck F
    Arzneimittelforschung; 1969 Sep; 19(9):1603-8. PubMed ID: 4310203
    [No Abstract]   [Full Text] [Related]  

  • 16. Potentiation of bradykinin by a factor present in the salivary gland of the rat.
    Santos RA; Cunha Melo JR; Heneine IF; Lauar NS; Beraldo WT
    Adv Exp Med Biol; 1979; 120B():581-7. PubMed ID: 517253
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of reserpine on the sensitivity of rat isolated uteri preparations to oxytocic drugs.
    Khan I; Qureshi Z
    J Pharm Pharmacol; 1967 Dec; 19(12):815-20. PubMed ID: 4383649
    [No Abstract]   [Full Text] [Related]  

  • 18. Fate of vasopressin and oxytocin in the pulmonary circulation.
    Biron P; Boileau JC
    Can J Physiol Pharmacol; 1969 Aug; 47(8):713-7. PubMed ID: 4389985
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of bradykinin on spontaneous and induced contractions of human uterine muscle in vitro.
    Belither A
    Can J Physiol Pharmacol; 1969 Feb; 47(2):223-6. PubMed ID: 5783168
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of polyphloretin phosphate on the response of non-gravid rat uterus to folkloric and standard oxytocics in vitro.
    Adebiyi A; Prasad RN; Adaikan PG
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(5-6):499-503. PubMed ID: 12144870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.